A detailed history of State Street Corp transactions in Absci Corp stock. As of the latest transaction made, State Street Corp holds 1,928,748 shares of ABSI stock, worth $5.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,928,748
Previous 1,947,181 0.95%
Holding current value
$5.17 Million
Previous $6 Million 22.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.97 - $4.49 $54,746 - $82,764
-18,433 Reduced 0.95%
1,928,748 $7.37 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $4.9 Million - $11 Million
1,677,817 Added 622.88%
1,947,181 $6 Million
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $158,565 - $266,910
46,500 Added 20.86%
269,364 $1.53 Million
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $36,800 - $153,280
32,000 Added 16.77%
222,864 $936,000
Q3 2023

Nov 14, 2023

SELL
$1.28 - $2.41 $48,000 - $90,375
-37,500 Reduced 16.42%
190,864 $251,000
Q2 2023

Aug 14, 2023

SELL
$1.17 - $2.03 $1.05 Million - $1.82 Million
-898,172 Reduced 79.73%
228,364 $347,000
Q1 2023

May 15, 2023

BUY
$1.58 - $3.41 $196,629 - $424,371
124,449 Added 12.42%
1,126,536 $1.97 Million
Q4 2022

Feb 14, 2023

BUY
$2.0 - $3.58 $29,124 - $52,131
14,562 Added 1.47%
1,002,087 $2.1 Million
Q3 2022

Nov 15, 2022

BUY
$2.95 - $4.83 $180,938 - $296,248
61,335 Added 6.62%
987,525 $3.09 Million
Q2 2022

Aug 15, 2022

BUY
$3.13 - $8.83 $642,905 - $1.81 Million
205,401 Added 28.5%
926,190 $3.08 Million
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $2.82 Million - $4.55 Million
480,506 Added 199.98%
720,789 $6.08 Million
Q4 2021

Feb 14, 2022

BUY
$7.88 - $18.03 $604,931 - $1.38 Million
76,768 Added 46.95%
240,283 $1.97 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $1.7 Million - $4.95 Million
163,515 New
163,515 $1.9 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.